237 related articles for article (PubMed ID: 18328786)
1. T-cell fate and function: PKC-theta and beyond.
Marsland BJ; Kopf M
Trends Immunol; 2008 Apr; 29(4):179-85. PubMed ID: 18328786
[TBL] [Abstract][Full Text] [Related]
2. Rottlerin inhibits human T cell responses.
Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
[TBL] [Abstract][Full Text] [Related]
3. A role for the immunological synapse in lineage commitment of CD4 lymphocytes.
Maldonado RA; Irvine DJ; Schreiber R; Glimcher LH
Nature; 2004 Sep; 431(7008):527-32. PubMed ID: 15386021
[TBL] [Abstract][Full Text] [Related]
4. Selective function of PKC-theta in T cells.
Manicassamy S; Gupta S; Sun Z
Cell Mol Immunol; 2006 Aug; 3(4):263-70. PubMed ID: 16978534
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C theta plays a fundamental role in different types of chronic colitis.
Nagahama K; Ogawa A; Shirane K; Shimomura Y; Sugimoto K; Mizoguchi A
Gastroenterology; 2008 Feb; 134(2):459-69. PubMed ID: 18155708
[TBL] [Abstract][Full Text] [Related]
6. Selective modulation of protein kinase C-theta during T-cell activation.
Monks CR; Kupfer H; Tamir I; Barlow A; Kupfer A
Nature; 1997 Jan; 385(6611):83-6. PubMed ID: 8985252
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.
Attig S; Hennenlotter J; Pawelec G; Klein G; Koch SD; Pircher H; Feyerabend S; Wernet D; Stenzl A; Rammensee HG; Gouttefangeas C
Cancer Res; 2009 Nov; 69(21):8412-9. PubMed ID: 19843860
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-dependent activation of CaV1.2 channels selectively controls human TH2-lymphocyte functions.
Robert V; Triffaux E; Paulet PE; Guéry JC; Pelletier L; Savignac M
J Allergy Clin Immunol; 2014 Apr; 133(4):1175-83. PubMed ID: 24365142
[TBL] [Abstract][Full Text] [Related]
9. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
Ramanathan S; Gagnon J; Ilangumaran S
Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses.
Monteleone G; Pallone F; MacDonald TT
Trends Immunol; 2008 Jun; 29(6):290-4. PubMed ID: 18440864
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 in the development and control of inflammatory disease.
Hoyer KK; Dooms H; Barron L; Abbas AK
Immunol Rev; 2008 Dec; 226():19-28. PubMed ID: 19161413
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors: paving the path to T cell-driven autoimmunity?
Marsland BJ; Kopf M
Curr Opin Immunol; 2007 Dec; 19(6):611-4. PubMed ID: 17888644
[TBL] [Abstract][Full Text] [Related]
13. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
[TBL] [Abstract][Full Text] [Related]
14. The significance of Treg cells in defective tumor immunity.
Kosmaczewska A; Ciszak L; Potoczek S; Frydecka I
Arch Immunol Ther Exp (Warsz); 2008; 56(3):181-91. PubMed ID: 18512029
[TBL] [Abstract][Full Text] [Related]
15. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45.
van Vliet SJ; Gringhuis SI; Geijtenbeek TB; van Kooyk Y
Nat Immunol; 2006 Nov; 7(11):1200-8. PubMed ID: 16998493
[TBL] [Abstract][Full Text] [Related]
16. Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.
Anderson K; Fitzgerald M; Dupont M; Wang T; Paz N; Dorsch M; Healy A; Xu Y; Ocain T; Schopf L; Jaffee B; Picarella D
Autoimmunity; 2006 Sep; 39(6):469-78. PubMed ID: 17060026
[TBL] [Abstract][Full Text] [Related]
17. Specifying helper T cell fates during immunity.
Chang JT; Reiner SL
J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E19-20. PubMed ID: 18354322
[No Abstract] [Full Text] [Related]
18. The importance of prolonged binding to antigen-presenting cells for T cell fate decisions.
Engelhardt JJ; Krummel MF
Immunity; 2008 Feb; 28(2):143-5. PubMed ID: 18275826
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses.
Marsland BJ; Soos TJ; Späth G; Littman DR; Kopf M
J Exp Med; 2004 Jul; 200(2):181-9. PubMed ID: 15263025
[TBL] [Abstract][Full Text] [Related]
20. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
